NeuroPace Pre-Tax Income 2020-2025 | NPCE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

NeuroPace pre-tax income from 2020 to 2025. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.

NeuroPace Pre-Tax Income 2020-2025 | NPCE

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

NeuroPace pre-tax income from 2020 to 2025. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$183.6B
Thermo Fisher Scientific (TMO)	$157.8B
Edwards Lifesciences (EW)	$45.1B
Alcon (ALC)	$42.4B
IDEXX Laboratories (IDXX)	$42.4B
DexCom (DXCM)	$33.2B
IQVIA Holdings (IQV)	$27.3B
Mettler-Toledo (MTD)	$24.3B
STERIS (STE)	$22.5B
Waters (WAT)	$17.2B
SONOVA HOLDING (SONVY)	$17.1B
Hologic (HOLX)	$14.1B
Sysmex ADR (SSMXY)	$10.4B
Penumbra (PEN)	$9.2B
Masimo (MASI)	$8.7B
Globus Medical (GMED)	$7.6B
Glaukos (GKOS)	$5.6B
Teleflex (TFX)	$5B
Integer Holdings (ITGR)	$4.1B
TransMedics (TMDX)	$3.9B
PROCEPT BioRobotics (PRCT)	$3.2B
LivaNova (LIVN)	$2.4B
Nihon Kohden (NHNKY)	$2B
Veracyte (VCYT)	$2B
Elekta AB (EKTAY)	$1.9B
Alphatec Holdings (ATEC)	$1.6B
Artivion (AORT)	$1.3B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B
Pulse Biosciences (PLSE)	$1B